Appendix E - National Coverage Determinations Manual / STEM_CELL_TRANSPLANTATION

Why This Topic Matters

Coverage for stem cell transplantation is highly diagnosis- and date-sensitive, so accurate interpretation affects claim acceptance, medical necessity review, and compliance with Medicare policy.

Article Sections

1. Stem Cell Transplantation

   Introduces the National Coverage Determination and the general scope of stem cell transplantation policy. Provides the policy context and effective-date framework.

2. A. General

   Defines the overall transplant process and distinguishes the main transplantation categories discussed in the policy. Sets the stage for the coverage discussion that follows.

3. 1. Allogeneic Stem Cell Transplantation

   Covers the allogeneic transplantation category and its policy structure. Includes coverage and noncoverage sections for this transplant type.

4. a. Covered Indications

   Lists the covered clinical circumstances associated with the allogeneic transplantation category. Presents the effective-date-specific coverage framework.

5. b. Noncovered Indications

   Identifies indications that are not covered for the allogeneic transplantation category. Notes the policy timing associated with the limitation.

6. 2. Autologous Stem Cell Transplantation (AuSCT)

   Covers the autologous transplantation category and its policy structure. Includes coverage and noncoverage sections for this transplant type.

7. a. Covered Indications

   Lists the covered clinical circumstances associated with the autologous transplantation category. Includes effective-date-specific coverage criteria and later policy updates.

8. b. Noncovered Indications

   Identifies conditions addressed as not covered or without sufficient evidence for the autologous transplantation category. Includes timing-related coverage limits and exclusions.

9. B. Other

   Describes how indications not specifically addressed in the national policy are handled. Clarifies the role of local contractor discretion.